BioSpace News Archive

Business

Lilly and Incyte communicate review extension of supplemental New Drug Application for baricitinib for the treatment of moderate to severe atopic dermatitis

Eli Lilly and Company (NYSE: LLY) and Incyte (NASDAQ:INCY) announced today that the U.S. Food and Drug Administration (FDA) has extended the review period for the supplemental New Drug Application (sNDA) for baricitinib for the treatment of adults with moderate to severe atopic dermatitis (AD).

April 6, 2021
·
12 min read
LigoLab’s Direct-to-Consumer Web Portal Supports School Surveillance Testing

TestDirectly connects medical labs with school districts for comprehensive and easy to implement COVID-19 testing solutions.

April 6, 2021
·
2 min read
Business

Juvenescence Appoints Dr. Grazia Piizzi as Chief Scientific Officer

Juvenescence Limited, a life sciences company focused on modifying aging and increasing human healthspan, announced that Dr. Grazia Piizzi, PhD, has joined its Executive Management Team as Chief Scientific Officer.

April 6, 2021
·
3 min read
Study Investigates the Effects of Ventilatory Rescue Therapies on the Cerebral Oxygenation of COVID-19 Patients Using Masimo O3®

Study Stresses the Importance of Brain Monitoring During the Treatment of Patients with Severe COVID-19

April 6, 2021
·
10 min read
Deals

Metrion Biosciences Closes £2.7m New Equity Financing

Metrion Biosciences Limited, the specialist ion channel CRO and drug discovery company, announced that it has secured £2.7m in new equity financing, including £2.25m from lead investor Gresham House Ventures.

April 6, 2021
·
2 min read
OBI Pharma Announces Poster Presentations at AACR 2021 Annual Meeting for OBI-3424, OBI-998, Globo H and SSEA-4

Poster Presentations to highlight the latest research on OBI-3424 (AKR1C3 small molecule pro-drug), OBI-998 (SSEA-4 ADC) and the glycosphingolipid cancer antigens, Globo H and SSEA-4.

April 6, 2021
·
4 min read
Deals

RadNet Announces a Proposed Refinancing Transaction for its $611 Million Senior Secured Term Loan and $195 Million Senior Secured Revolving Credit Facility

RadNet, Inc. announced a proposed refinancing transaction for its existing senior secured first lien term loan, which had a balance of $611 million as of December 31, 2020, and its $195 million senior secured revolving credit facility, which was undrawn as of year-end 2020.

April 6, 2021
·
4 min read
Policy

Amarin Commences Commercial Initiatives for VAZKEPA in European Union Following Recent Regulatory Approval for Cardiovascular Risk Reduction Indication

Amarin Corporation plc provided updates regarding its plans for the commercial launch of VAZKEPA in Europe following the March 30, 2021 announcement of receipt of market authorization from the European Commission.

April 6, 2021
·
16 min read
Biotech Beach

DuchenneXchange Launches V2.0 As Rare Disease Community Seeks “Safe” Place To Discuss Treatment, Research, COVID-19 Immunization And Other Critical Topics

The volatility of the past year has created additional strain on families grappling with Duchenne muscular dystrophy, a severe X-linked form of muscular dystrophy that affects approximately 1 in 3,500 to 5,000 males born each year.

April 6, 2021
·
4 min read
Policy

Biodesix Announces Issuance of Two U.S. Patents, Expands Coverage of Diagnostic Methods to Improve Care for Cancer Patients

Diagnostic Test and Novel Methodologies Designed to Guide Patient Assessment and Treatment Strategies

April 6, 2021
·
5 min read